Deccan Health Care Limited (BOM:542248)
13.28
+0.27 (2.08%)
At close: Mar 6, 2026
Deccan Health Care Revenue
Deccan Health Care had revenue of 173.94M INR in the quarter ending December 31, 2025, a decrease of -14.86%. This brings the company's revenue in the last twelve months to 816.77M, up 16.22% year-over-year. In the fiscal year ending March 31, 2025, Deccan Health Care had annual revenue of 750.58M with 25.66% growth.
Revenue (ttm)
816.77M
Revenue Growth
+16.22%
P/S Ratio
0.37
Revenue / Employee
9.84M
Employees
83
Market Cap
304.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 750.58M | 153.29M | 25.66% |
| Mar 31, 2024 | 597.29M | 147.07M | 32.67% |
| Mar 31, 2023 | 450.22M | 118.50M | 35.72% |
| Mar 31, 2022 | 331.71M | -6.05M | -1.79% |
| Mar 31, 2021 | 337.76M | -84.68M | -20.05% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Mangalam Drugs & Organics | 2.38B |
| ANG Lifesciences India | 862.13M |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Sandu Pharmaceuticals | 671.50M |
| Panjon | 493.34M |